Reports

U.S. hospitals have been closely scrutinizing their capital and operating costs for imaging equipment. With continued pressure on their revenue sources, coverage for equipment maintenance, repair, and value-added services continue to be critical considerations in such budgetary decisions. As their use and deployment of imaging equipment continues to grow, hospitals and healthcare systems are seeking…

As life science researchers continue to elevate their experience expectations, understanding current perceptions of customer experience enables suppliers to identify areas of improvement and benchmark against their key competitors. In 2025, we continued a longitudinal study to support suppliers looking to improve their customer experience strategy. The outcome is our latest report, Benchmarking for 2025: Understanding…

This study offers an in-depth analysis of the performance of 11 different manufacturers with a deep dive into how a variety of touch points across the customer journey shapes customer experience scores. We asked 300 diagnostic imaging professionals to evaluate their experiences during specific touchpoints with OEMs, such as product awareness, selection, service, and support.…

Kalorama Information’s Biomarkers in Diagnostics: Global Strategic Insights and Forecasts to 2031 provides a comprehensive analysis of the worldwide clinical diagnostic biomarker market, with forecasts from 2022 through 2031. The report examines diagnostic substances and tests used for disease detection, therapy selection, disease monitoring, and evaluation of treatment effectiveness across seven major product categories: infectious…

The Cell and Gene Therapy Tools & Products report provides a comprehensive analysis of the global market for tools and products used in cell and gene therapy (C&GT) research and development. It examines market size, growth dynamics, and technological advancements across seven major categories of laboratory instrumentation and consumables: general techniques, gene therapy tools, transduction…

Kalorama Information’s The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 18th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2025 to 2030, and essential insights needed to understand the IVD market in its entirety. With…

IMV’s 2025 Neurology in Diagnostic Imaging Market Outlook Report explores neurology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, and site operations characteristics. Survey results are projected to the identified universe of neurology-related imaging…

Software systems underpin nearly all advanced technologies, procedures, and data analytics in laboratories—whether involved in routine sample analysis or complex research activities. The automation capabilities they provide allow scientists to streamline workflows, set analytical parameters, comply with regulatory requirements, and record, organize, and analyze data. Their very existence makes high-throughput testing possible, and their capabilities…

Kalorama Information’s Point-of-Care (POC) Urinalysis and Urinalysis Drugs of Abuse Testing Market, 2025 provides an in-depth analysis of the global market for point-of-care urinalysis and drugs of abuse testing. The report examines current market dynamics, technological trends, and future growth potential, with revenue forecasts through 2029.

Point-of-care testing encompasses diagnostic procedures performed near the patient,…

This report presents findings from a comprehensive survey of clinical diagnostics professionals, across multiple years (2019, 2020, 2022, and 2025), focusing on their experiences with vendors, product usage, purchasing behavior, and operational challenges. The findings offer actionable insights to enhance customer engagement, support product innovation, and improve service delivery across the IVD industry. These insights…

Artificial intelligence (AI) is influencing healthcare in countless ways, and its impact on diagnostic imaging is one of the greatest. This is due to the dependence on visual examination, demand for increased procedures, more data analysis required per scan, error/cost reduction, and the development of specific computing tools that make AI-guided decisions far more practical.

…

IMV’s 2023 Oncology in Diagnostic Imaging Market Outlook Report explores oncology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, trends, and site operations characteristics. Survey results are projected to the identified universe of…